化合物的抗神经炎症作用 隔离自Quercus acuta Thunb. 的化合物 水果通过NF-κB信号抑制在BV2微质中
Hwan Lee1, Yezhi Jin2, Ji-Ae Hong1
1Natural Resources Laboratory, Green Bio Headquarters, Jeonnam Bio Foundation (JBF), Jangheung-gun 59338, Jeollanam-do, Republic of Korea.
Molecules (Basel, Switzerland)
|December 11, 2025
概括
这项研究确定了来自Quercus acuta水果的两种化合物具有显著的抗神经炎症作用. 这些天然化合物显示出治疗与年龄相关的神经炎症和相关疾病的潜力.
科学领域:
- 药理学 药理学是指药理学的学科.
- 神经科学是一个神经科学.
- 自然产品 化学 化学
背景情况:
- 老龄化增加了神经退行性疾病的风险.
- 微质驱动的神经炎症是神经元功能障碍和疾病进展的关键.
研究的目的:
- 从Quercus acuta水果中分离出生物活性代谢物.
- 评估这些化合物的抗神经炎症潜力.
主要方法:
- 从Q. acuta水果提取物中对14种化合物的生物活性导向的分离.
- 使用NMR光谱的结构识别.
- 对LPS诱导的BV2微质中抗神经炎症活性的测定.
主要成果:
- 3,5,7,2',6'-pentahydroxyflavanone和2,5-dihydroxybenzaldehyde显示出显著的抗神经炎症活性.
- 减少IL-6和TNF-α的产生.
- 抑制了iNOS,COX-2表达和NF-κB激活.
结论:
- 花果 (Quercus acuta) 含有具有抗神经炎症功能的新生物活性成分.
- 这些化合物可以作为治疗年龄相关神经炎症的治疗剂.
- 支持Q. acuta在东方医学中的传统使用.
相关概念视频
NF-κB-dependent Signaling Pathway
9.7K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
9.7K
Gene Regulation in Microbial Communities: Quorum Sensing
463
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
463
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
790
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
790


